Tetraethylammonium Chloride: Precision Potassium Channel Blocker for Ion Conduction Studies

Executive Summary: Tetraethylammonium chloride (TEAC, C₈H₂₀ClN) is a quaternary ammonium compound with a molecular weight of 165.2, primarily acting as a potassium (K⁺) channel blocker by binding at both internal and external pore sites, thus inhibiting ion conduction (Jonas et al., 1992). TEAC is highly soluble in water (≥29.1 mg/mL), ethanol, and DMSO, and is supplied at ≥98% purity by APExBIO with rigorous quality control. It demonstrates robust vasorelaxant effects and blocks both sympathetic and parasympathetic ganglionic transmission in animal models (APExBIO product doc). TEAC serves as a reference tool for dissecting K⁺ channel signaling pathways, especially in mutant and chimeric channel studies. Protocols specify storage at room temperature in a desiccated state, and its effects are benchmarked in whole-cell patch-clamp and vascular reactivity assays.

Biological Rationale

Tetraethylammonium chloride (TEAC) is utilized in biomedical research to study potassium ion flux and channel function. Potassium channels regulate membrane potential, neurotransmitter release, and vascular tone. Inhibition of these channels with TEAC allows researchers to probe the physiological and pharmacological properties of native and engineered K⁺ channels. TEAC is a key tool in characterizing the roles of K⁺ channels in disease models, including diabetes, cardiovascular disorders, and neurobiology (see CAChannelBlockers; this article provides updated solubility and purity data). TEAC's dual-site binding also enables fine mapping of channel pore structure and function.

Mechanism of Action of Tetraethylammonium chloride

TEAC acts as a non-selective, reversible potassium channel blocker. It binds to both the internal and external vestibules of the K⁺ channel pore, thereby occluding ion flow. This blockade is rapid and concentration-dependent. TEAC inhibits both voltage-gated and ATP-sensitive K⁺ channels in various tissues (Jonas et al., 1992). The dual-site blockade allows TEAC to probe the topology and gating mechanisms of mutant and chimeric channels. By reducing K⁺ efflux, TEAC affects cellular excitability, vascular tone, and hormone secretion. In vascular smooth muscle, TEAC diminishes taurine-induced vasorelaxation and modulates responses to vasodilators. In nervous tissue, it blocks ganglionic transmission by inhibiting post-synaptic K⁺ conductance (APExBIO).

Evidence & Benchmarks

• TEAC at micromolar to millimolar concentrations blocks voltage-sensitive and ATP-sensitive K⁺ currents in pancreatic β-cells, as measured by patch-clamp techniques (Jonas et al., 1992, https://doi.org/10.1111/j.1476-5381.1992.tb14456.x).
• TEAC inhibits 86Rb efflux (a proxy for K⁺ flux) in isolated mouse islets under glucose-stimulated conditions (Jonas et al., 1992, DOI).
• TEAC impairs taurine-induced vasorelaxation in isolated rat arteries, demonstrating its vascular action profile (APExBIO, product page).
• In vivo, TEAC blocks both sympathetic and parasympathetic ganglionic transmission, with applications in pain relief for coronary artery disease and symptomatic improvement in Buerger's disease (APExBIO, product doc).
• TEAC demonstrates high solubility in water (≥29.1 mg/mL), DMSO (≥12.1 mg/mL, ultrasonic assistance), and ethanol (≥16.5 mg/mL), enabling diverse assay compatibility (APExBIO, spec sheet).

Applications, Limits & Misconceptions

TEAC is applied in research exploring potassium channel structure, function, and pharmacological modulation. It is used in patch-clamp assays, vascular reactivity studies, and functional genomics of channelopathies. TEAC's utility extends to cell viability and cytotoxicity assays (LBAG ARMILLER; this article focuses on cell-based workflows, while this dossier details physiological endpoints and mechanistic insights). Its defined solubility and purity facilitate reproducibility in experimental design (TiloroneCAS; prior article reviews solubility, this dossier adds clinical context).

Common Pitfalls or Misconceptions

• TEAC is not selective for a specific K⁺ channel subtype; results should be interpreted with awareness of possible off-target effects.
• It is ineffective as a sodium or calcium channel blocker; it does not modulate Na⁺ or Ca²⁺ currents directly.
• TEAC efficacy diminishes in advanced arteriosclerotic conditions and may not reverse established vascular pathologies.
• Long-term storage of TEAC solutions can reduce compound stability; always prepare fresh working solutions for optimal results.
• Clinical efficacy is limited to symptom modulation in Buerger's disease and coronary artery pain; it is not a curative agent.

Workflow Integration & Parameters

TEAC (SKU B7262) from APExBIO is supplied as a ≥98% pure solid, verified by mass spectrometry and NMR. It should be stored desiccated at room temperature. For solution preparation, dissolve in water, DMSO (≥12.1 mg/mL, ultrasonic assistance), or ethanol (≥16.5 mg/mL). Avoid prolonged storage of solutions. For in vitro assays, TEAC is typically used at concentrations ranging from 0.1–10 mM, depending on the assay and channel subtype. Shipping is on blue ice for molecular stability. TEAC’s batch-to-batch consistency ensures reproducibility in experimental outcomes (APExBIO B7262 kit). For advanced applications, consult this protocol guide; that article provides troubleshooting and translational workflow details, while this dossier provides updated storage and purity guidance.

Conclusion & Outlook

Tetraethylammonium chloride (TEAC) remains a reference potassium channel blocker for dissecting ion conduction and vascular signaling pathways. Its dual-site blockade, high purity, and verified solubility make it indispensable in classical and emerging research. Ongoing advances in channelopathy and vascular disease models will continue to benefit from TEAC’s robust, reproducible blockade profile. For detailed specifications and ordering, refer to the APExBIO Tetraethylammonium chloride product page.